Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-09-11

Clinical Trial Update: Combining HIIT and n-3 PUFA Supplementation to Reduce Inflammation and Improve Metabolic Health (HIIT&PUFA) [NA]

View source ↗

Summary

The HIIT&PUFA trial examining high-intensity interval training plus omega-3 fatty acid supplementation for obesity-related inflammation and metabolic health has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (EPA/DHA) supplement (Omega-3 fatty acids)

Snippet

Sponsor: Texas Tech University | Conditions: Obesity, Inflammation | NA | Status: WITHDRAWN